Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Beatrice Osumili"'
Autor:
Jeremy W Coid, Simone Ullrich, Constantinos Kallis, Mark Freestone, Rafael Gonzalez, Laura Bui, Artemis Igoumenou, Anthony Constantinou, Norman Fenton, William Marsh, Min Yang, Bianca DeStavola, Junmei Hu, Jenny Shaw, Mike Doyle, Laura Archer-Power, Mary Davoren, Beatrice Osumili, Paul McCrone, Katherine Barrett, David Hindle, Paul Bebbington
Publikováno v:
Programme Grants for Applied Research, Vol 4, Iss 16 (2016)
Background: Mental health professionals increasingly carry out risk assessments to prevent future violence by their patients. However, there are problems with accuracy and these assessments do not always translate into successful risk management. Obj
Externí odkaz:
https://doaj.org/article/115317e033584dd6993e2e4fb2b92c7b
Autor:
Heather L Gelhorn, Beatrice Osumili, Katelyn Brown, Melissa M Ross, Andrea Schulz, Gabriela Fernandez, Kristina S Boye
Publikováno v:
Patient Preference and Adherence. 17:793-805
Heather L Gelhorn,1 Beatrice Osumili,2 Katelyn Brown,2 Melissa M Ross,1 Andrea Schulz,1 Gabriela Fernandez,1 Kristina S Boye2 1Patient-Centered Research, Evidera, Inc., Bethesda, MD, USA; 2Value, Evidence, and Outcomes, Eli Lilly and Company, Indiana
Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain
Autor:
Beatrice Osumili, Esther Artime, Beth Mitchell, Miriam Rubio-de Santos, Silvia Díaz-Cerezo, Marga Giménez, Erik Spaepen, Helen Sharland, William J. Valentine
Publikováno v:
Diabetes Therapy. 13:775-794
Severe hypoglycemic events (SHE) represent a clinical and economic burden in patients with diabetes. Nasal glucagon (NG) is a novel treatment for SHEs with similar efficacy, but with a usability advantage over injectable glucagon (IG) that may transl
Autor:
Jean-François Yale, Beatrice Osumili, Beth D. Mitchell, Barnaby Hunt, Gurjeev Sohi, Mark Jeddi, Donna Mojdami, William J. Valentine
Publikováno v:
Journal of Medical Economics. 25:238-248
Treatments for severe hypoglycemia aim to restore blood glucose through successful administration of rescue therapy, and choosing the most effective and cost-effective option will improve outcomes for patients and may reduce costs for healthcare paye
Autor:
Mark Peyrot, Miriam Rubio, Frank J. Snoek, Robin Pokrzywinski, Esther Artime, Jesús Reviriego, F. Javier Ampudia-Blasco, Beth Mitchell, Erik Spaepen, Silvia Díaz, Beatrice Osumili
Publikováno v:
Endocrinología, Diabetes y Nutrición (English ed.). 68:557-566
Introduction Information on experience/management of severe hypoglycaemic events (SHEs) among people with insulin-treated diabetes (PWD) and caregivers (CGs) providing care to PWD was sought. Materials and methods An online cross-sectional survey was
Autor:
Beth D. Mitchell, Anne M. Rentz, Shannon Kummer, Yu Yan, Sebastian Heidenreich, Nicolas Krucien, Esther Artime, Beatrice Osumili, Miriam Rubio, Heather L. Gelhorn
Publikováno v:
Journal of diabetes science and technology.
Background: Conventional injectable glucagon (IG) and nasal glucagon (NG), both having similar efficacy, are two options for the emergency treatment of severe hypoglycemia in Spain. This study elicited the effect of changes in key attributes on prefe
Autor:
Richard F. Pollock, Kirsi Norrbacka, Kristina S. Boye, Beatrice Osumili, William J. Valentine
Publikováno v:
Journal of medical economics. 25(1)
The growing burden of diabetes mellitus and recent progress in understanding cardiovascular outcomes for type 2 diabetes (T2D) patients continue to make the disease a priority for healthcare decision-makers around the world. Our objective was to deve
Autor:
Nicolas Chevalier, Alfred Penfornis, Jean-Pierre Riveline, Florence Chartier, Beth Mitchell, Beatrice Osumili, Erik Spaepen, Frank Snoek, Mark Peyrot, Imane Benabbad
Publikováno v:
Annales d'endocrinologie. 83(1)
The objective of the CRASH (Conversations and Reactions Around Severe Hypoglycemia) survey was to further our understanding of the characteristics, experience, behavior and conversations with healthcare professionals (HCPs) of people with diabetes (P
Autor:
Jieling Chen, Carolina Piras De Oliveira, Magaly Perez-Nieves, Matthias Blüher, Barbara Thun, Nanette C. Schloot, Erik Spaepen, Beatrice Osumili, Paul T. Williams, Jiat-Ling Poon
Publikováno v:
Diabetes Therapy
Introduction The study was designed to assess patient satisfaction, preferences and injection habits for patients using insulin lispro 200 units/ml pen (IL200) compared to their previously used disposable 100 units/ml mealtime insulin pen (“MTI-100
Autor:
Hayley Karn, Louis S. Matza, Jessica B Jordan, Silvia Del Santo, Beatrice Osumili, Gordon Parola, Katie D. Stewart, Serena Losi, Giovanni Biricolti, Magaly Perez-Nieves, Kristina S. Boye, Erik Spaepen, Ester Romoli
Publikováno v:
Diabetes Therapy
Introduction Standard concentration (100 units/mL) mealtime insulin is frequently used to treat patients with type 1 (T1D) and type 2 diabetes (T2D). A more concentrated version of the medication (200 units/mL) has been available in Italy since 2016.